Ischemic stroke and the fate of cerebral microvessels.
Rinsho Shinkeigaku., 52(11):826 (2012)
Immunologic privilege in the central nervous system and the blood-brain barrier.
J. Cereb. Blood Flow Metab., Oct (2012)
Toward the Neurovascular Unit A Journey in Clinical Translation: 2012 Thomas Willis Lecture.
Stroke., Oct (2012)
Use of gel zymography to examine matrix metalloproteinase (gelatinase) expression in brain tissue or in primary glial cultures.
Methods Mol. Biol., 814:221-33 (2012)
Approach to the treatment, characterization and diagnosis of an acquired auto-antibody directed against factors prothrombin, factor X and factor IX: a case report and review of the literature.
Haemophilia., Jan;18(1):102-7 (2012)
Thrombolysis for acute ischaemic stroke.
Cochrane Database Syst Rev., (4):CD000213 (2009)
Bleeding in the brain: Amyloid-beta may keep clots away.
Nat. Med., Oct;15(10):1132-3 (2009)
Expansion of the time window for treatment of acute ischemic stroke with intravenous tissue plasminogen activator: a science advisory from the American Heart Association/American Stroke Association.
Stroke., Aug;40(8):2945-8 (2009)
Vascular matrix adhesion and the blood-brain barrier.
Biochem. Soc. Trans., Dec;34(Pt 6):1261-6 (2006)
Focal cerebral ischemia and hemostasis: a PAI-1 conundrum.
J. Thromb. Haemost., Jul;3(7):1376-8 (2005)
Distribution of integrin-like immunoreactivity on primate brain microvasculature.
J. Neuropathol. Exp. Neurol., Feb;55(2):236-45 (1996)
Why do all drugs work in animals but none in stroke patients? 1. Drugs promoting cerebral blood flow.
J. Intern. Med., Jan;237(1):79-88 (1995)
Brief report: reversible lymphomas associated with Epstein-Barr virus occurring during methotrexate therapy for rheumatoid arthritis and dermatomyositis.
N. Engl. J. Med., May;328(18):1317-21 (1993)